Moderna Inc logo

Moderna Inc

€ 145.88 (-3.93%) Aug 19
P/E:
4.49
P/B:
3.20
Market Cap:
€ 56.65B ($ 56.88B)
Enterprise V:
€ 49.70B ($ 49.91B)
Volume:
900.00
Avg Vol (2M):
609.00
Also Trade In:
Volume:
900.00
Market Cap €:
56.65B
Market Cap $:
56.88B
PE Ratio:
4.49
Avg Vol (2-Month):
609.00
Enterprise Value €:
49.70B
Enterprise Value $:
49.91B
PB Ratio:
3.20
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Moderna Inc
NAICS : 325412 SIC : 2836
200 Technology Square, Cambridge, MA, USA, 02139
Description
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 8.9
Equity-to-Asset 0.69
Debt-to-Equity 0.05
Debt-to-EBITDA 0.06
Interest Coverage 739.37
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 8.61
Distress
Grey
Safe
Beneish M-Score 0.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 19.28
9-Day RSI 30.4
14-Day RSI 37.84
6-1 Month Momentum % 27.49
12-1 Month Momentum % -50.07

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.99
Quick Ratio 1.71
Cash Ratio 1.16
Days Inventory 123.91
Days Sales Outstanding 46.52
Days Payable 15.17

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7

Financials (Next Earnings Date:2022-11-04 Est.)

WBO:MRNA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 19,967.471
EPS (TTM) (€) 29.285
Beta 0
Volatility % 56.04
14-Day RSI 37.84
14-Day ATR (€) 7.010418
20-Day SMA (€) 165.344
12-1 Month Momentum % -50.07
52-Week Range (€) 112.58 - 386.7
Shares Outstanding (Mil) 391.2

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Moderna Inc Filings

Document Form Filing Date
No Filing Data